BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
DEL PRIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionMackenzie Financial Corp
Latest Disclosed Ownership441,444 shares
Latest Disclosed Value $ 24,937,172
Mackenzie Financial Corp reports 17.70% increase in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 13, 2026 - Mackenzie Financial Corp filed a 13F-HR form disclosing ownership of 441,444 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $21,180,483 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 375,067 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 17.70% during the quarter. The current value of the position is $20,566,876 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 441,444 66,377 17.70 24,937 12.93 0.0299
2026-02-18 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 375,067 199,840 114.05 22,082 132.68 0.0262
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 175,227 53,164 43.55 9,490 41.45 0.0115
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 122,063 53,798 78.81 6,710 39.05 0.0087
2025-05-07 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 68,265 -152,396 -69.06 4,826 -66.73 0.0069
2025-05-02 2024-12-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 220,661 147,927 203.38 14,504 183.72 0.0198
2025-02-20 2024-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 220,661 147,927 14,504 0.0188
2025-02-14 2024-12-31 13F BioMarin Pharmaceutical Common Stock 09061G101 220,661 147,927 13,873 0.0199
2024-11-13 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 72,734 42,260 138.68 5,112 103.83 0.0071
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,474 4,832 18.84 2,509 12.01 0.0037
2024-05-10 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,642 -9,980 -28.02 2,240 -34.80 0.0032
2024-01-30 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,622 -674 -1.86 3,435 9.78 0.0052
2023-10-25 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 36,296 6,280 20.92 3,128 21.33 0.0053
2023-08-03 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,016 -15,720 -34.37 2,578 -42.03 0.0039
2023-04-24 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,736 800 1.78 4,447 -4.37 0.0069
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 44,936 2,165 5.06 4,650 28.24 0.0078
2022-10-07 2022-09-30 13F BioMarin Pharmaceutical Common Stock 09061G101 42,771 -31,204 -42.18 3,626 -40.85 0.0062
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 73,975 -41,988 -36.21 6,130 -31.44 0.0098
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115,963 -3,671 -3.07 8,941 -15.41 0.0120
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 119,634 34,580 40.66 10,570 60.78 0.0142
2021-11-08 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 85,054 25,620 43.11 6,574 32.57 0.0093
2021-08-11 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 59,434 -1,786 -2.92 4,959 7.27 0.0069
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 61,220 53,279 670.94 4,623 564.22 0.0070
2021-02-10 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,941 1,003 14.46 696 31.82 0.0015
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,938 1,886 37.33 528 -15.25 0.0013
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,052 1,106 28.03 623 87.09 0.0017
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,946 3,946 333 0.0011
2019-08-23 2019-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 0 -46,057 -100.00 0 -100.00
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 46,057 -64,523 -58.35 4,091 -56.55 0.0099
2019-02-06 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 110,580 110,580 9,416 0.0248
2016-11-15 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -12,138 -100.00 0 -100.00
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,138 138 1.15 944 -4.65 0.0053
2016-05-12 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,000 2,600 27.66 990 0.51 0.0090
2016-02-12 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,400 300 3.30 985 2.82 0.0061
2015-11-13 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,100 1,100 13.75 958 -12.43 0.0058
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,000 200 2.56 1,094 12.55 0.0059
2015-05-13 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,800 -40,500 -83.85 972 -77.74 0.0051
2015-02-11 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 48,300 -51,600 -51.65 4,366 -39.44 0.0223
2014-11-12 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 99,900 6,500 6.96 7,209 24.08 0.0361
2014-08-11 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 93,400 1,200 1.30 5,810 -7.62 0.0270
2014-05-14 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 92,200 3,800 4.30 6,289 1.13 0.0308
2014-02-11 2013-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 88,400 3,000 3.51 6,219 0.91 0.0314
2014-02-03 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 88,400 6,219
2013-11-12 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 85,400 -25,700 -23.13 6,163 -0.48 0.0312
2013-08-20 2013-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 111,100 111,100 6,193 0.0295
2013-08-09 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 111,100 6,193 0.0296
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.